C57BL/6 Mouse Aortic Endothelial Cells

Cat.No.: CSC-C1861

Species: Mouse

Source: Aorta

Cell Type: Endothelial Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C1861
Description
C57BL/6 Mouse Aortic Endothelial Cells from Creative Bioarray are isolated from aorta of pathogen-free laboratory mice. C57BL/6 Mouse Aortic Endothelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based coating solution for 2 min and incubated in Creative Bioarray’ Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells are detached from flasks and immediately cryo-preserved in vials. Each vial contains at least 1x10^6 cells per ml and are delivered frozen. The method we use to isolate endothelial cells was developed based on a combination of established and our proprietary methods. These cells are pre-coated with PECAM-1 antibody, following the application of magnetic pre-coated with secondary antibody.
Species
Mouse
Source
Aorta
Recommended Medium
Complete Mouse Endothelial Cell Culture Medium
Cell Type
Endothelial Cell
Disease
Normal
Quality Control
C57BL/6 Mouse Aortic Endothelial Cells are tested for expression of markers using antibody, VE-cadherin (CD144, VE-cadherin Antibody, C-19, sc6458, Santa Cruz); AF1002 (R&D System) or CD31/PECAM-1 (Purified Rat Anti-Mouse CD31, Catalog No. 553370, BD) by immunofluorescence staining or FACS. C57BL/6 Mouse Aortic Endothelial Cells are negative for bacteria, yeast, fungi and mycoplasma. Cells can be expanded for 3-6 passages at a split ratio of 1:2 under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Live cell shipment is also available on request. Never can primary cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

C57BL/6 Mouse Aortic Endothelial Cells represent primary endothelial cells that scientists derive from the aorta of C57BL/6 mice. These cells serve as an in vitro model system for vascular biology research and understanding the mechanisms of cardiovascular diseases. Endothelial cells (ECs) line the interior surface of blood vessels and are involved in various physiological and pathological processes. Characteristics like supporting vasomotion, vascular permeability, inflammation, and thrombosis make them ideal models for studying endothelial function and dysfunction.

C57BL/6 mouse aortic endothelial cells grown in vitro develop the characteristic cobblestone morphology and establish contact-inhibited monolayer formations. These cells express endothelial cell markers such as CD31/PECAM-1, VE-cadherin, von Willebrand factor (vWF), and endothelial nitric oxide synthase (eNOS). Mouse aortic endothelial cells respond to physical and chemical stimuli such as shear stress, cytokines, and reactive oxygen species. Additionally, they play an active role in angiogenic signaling pathways and vascular remodeling processes. Isolated from a common inbred mouse strain (C57BL/6), they have good genetic uniformity and are compatible with many mouse disease models. C57BL/6 mouse aortic endothelial cells are widely used to study atherosclerosis, hypertension, endothelial inflammation, diabetes, and drug-induced toxicity.

Sunitinib Leads to Decrease in Mams in Mouse Aortic Endothelial Cells and HUVECs

TKIs like sunitinib cause hypertension, but the mechanisms are unknown. Here, Qu's team performed in vitro and in vivo experiments to assess ROS, NO, endothelium-dependent vasorelaxation, blood pressure, and mitochondrial function in HUVECs and C57BL/6 mouse aortic endothelial cells under sunitinib treatment. Results showed that sunitinib increased mitochondrial ROS, decreased OCR, ATP production, and [Ca2+]M levels, and impaired eNOS and NO signaling.

Purifying MAMs (Mitochondria-Associated Membranes) has shown a physical link between the ER (Endoplasmic Reticulum) and mitochondria, with gaps of 6-15 nm. MAMs are vital for mitochondrial function, so we tested if sunitinib affects them. TEM (Transmission Electron Microscopy) showed sunitinib reduced MAMs in mouse aortic endothelial cells and HUVECs (Human Umbilical Vein Endothelial Cells) (Fig. 1A-D). Confocal images also showed less ER-mitochondria overlap and mitochondrial elongation in sunitinib-treated HUVECs (Fig. 1E-H).

Sunitinib induces reduction in MAMs, mitochondrial elongation, and increases mitofusin 2 expression in ECs.

Fig. 1. Sunitinib induces reduction in MAMs, mitochondrial elongation, and increases mitofusin 2 expression in ECs (Qu Y, Liu Z X, et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products